These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Coexisting gout, erythrodermic psoriasis and psoriatic arthritis. Liu M; Li JH; Li B; He CD; Xiao T; Chen HD Eur J Dermatol; 2009; 19(2):184-5. PubMed ID: 19106055 [No Abstract] [Full Text] [Related]
3. Comorbidities in patients with psoriasis. Gottlieb AB; Dann F Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894 [TBL] [Abstract][Full Text] [Related]
4. Long-term prognosis in patients with psoriasis. Gulliver W Br J Dermatol; 2008 Aug; 159 Suppl 2():2-9. PubMed ID: 18700909 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence. Johnsson H; McInnes IB; Sattar N Ann Rheum Dis; 2012 Apr; 71(4):480-3. PubMed ID: 22294632 [TBL] [Abstract][Full Text] [Related]
6. Psoriasis comorbidities. Gottlieb AB; Chao C; Dann F J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720 [TBL] [Abstract][Full Text] [Related]
8. Psoriasis: cardiovascular risk factors and other disease comorbidities. Wu Y; Mills D; Bala M J Drugs Dermatol; 2008 Apr; 7(4):373-7. PubMed ID: 18459519 [TBL] [Abstract][Full Text] [Related]
9. Participation, satisfaction and knowledge level of patients with cutaneous psoriasis or psoriatic arthritis. Renzi C; Di Pietro C; Tabolli S Clin Exp Dermatol; 2011 Dec; 36(8):885-8. PubMed ID: 21790723 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives. Boehncke WH; Boehncke S Curr Rheumatol Rep; 2012 Aug; 14(4):343-8. PubMed ID: 22562431 [TBL] [Abstract][Full Text] [Related]
15. Research in practice: the systemic aspects of psoriasis. Boehncke WH; Boehncke S J Dtsch Dermatol Ges; 2008 Aug; 6(8):622-5. PubMed ID: 18564207 [TBL] [Abstract][Full Text] [Related]
16. Psoriasis and metabolic comorbidities: the importance of well-designed prospective studies. Commentary. Girolomoni G; Gisondi P Dermatology; 2008; 217(3):222-4. PubMed ID: 18663303 [No Abstract] [Full Text] [Related]
17. Psoriasis, the liver, and the gastrointestinal tract. Gisondi P; Del Giglio M; Cozzi A; Girolomoni G Dermatol Ther; 2010; 23(2):155-9. PubMed ID: 20415823 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Diseases in Psoriasis and Psoriatic Arthritis. Eder L; Dey A; Joshi AA; Boehncke WH; Mehta NN; Szentpetery A J Rheumatol Suppl; 2019 Jun; 95():20-27. PubMed ID: 31154400 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Gisondi P; Girolomoni G; Sampogna F; Tabolli S; Abeni D Eur J Dermatol; 2005; 15(4):279-83. PubMed ID: 16048759 [TBL] [Abstract][Full Text] [Related]
20. Psoriasis more than skin deep. Van de Kerkhof PC J Dermatolog Treat; 2008; 19(1):4. PubMed ID: 18273719 [No Abstract] [Full Text] [Related] [Next] [New Search]